Cabio Biotech (Wuhan) Co., Ltd. 688089.SS Stock
Cabio Biotech (Wuhan) Co., Ltd. Price Chart
Cabio Biotech (Wuhan) Co., Ltd. 688089.SS Financial and Trading Overview
| Cabio Biotech (Wuhan) Co., Ltd. stock price | 13.36 CNY |
| Previous Close | 29.26 CNY |
| Open | 29.26 CNY |
| Bid | 29.02 CNY x N/A |
| Ask | 29.04 CNY x N/A |
| Day's Range | 28.66 - 29.51 CNY |
| 52 Week Range | 26.7 - 54.57 CNY |
| Volume | 1.62M CNY |
| Avg. Volume | 1.57M CNY |
| Market Cap | 3.49B CNY |
| Beta (5Y Monthly) | 0.502891 |
| PE Ratio (TTM) | 61.787235 |
| EPS (TTM) | 0.1 CNY |
| Forward Dividend & Yield | 0.33 (1.11%) |
| Ex-Dividend Date | July 14, 2022 |
| 1y Target Est | 56.83 CNY |
688089.SS Valuation Measures
| Enterprise Value | 3.24B CNY |
| Trailing P/E | 61.787235 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.8340898 |
| Price/Book (mrq) | 2.4264705 |
| Enterprise Value/Revenue | 7.262 |
| Enterprise Value/EBITDA | 37.291 |
Trading Information
Cabio Biotech (Wuhan) Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.502891 |
| 52-Week Change | -9.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 54.57 CNY |
| 52 Week Low | 26.7 CNY |
| 50-Day Moving Average | 32.51 CNY |
| 200-Day Moving Average | 41.48 CNY |
688089.SS Share Statistics
| Avg. Volume (3 month) | 1.57M CNY |
| Avg. Daily Volume (10-Days) | 1.65M CNY |
| Shares Outstanding | 120.22M |
| Float | 60.41M |
| Short Ratio | N/A |
| % Held by Insiders | 52.78% |
| % Held by Institutions | 6.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 1.02% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.44% |
| Operating Margin (ttm) | 13.59% |
| Gross Margin | 39.82% |
| EBITDA Margin | 19.47% |
Management Effectiveness
| Return on Assets (ttm) | 2.47% |
| Return on Equity (ttm) | 3.72% |
Income Statement
| Revenue (ttm) | 445.64M CNY |
| Revenue Per Share (ttm) | 3.76 CNY |
| Quarterly Revenue Growth (yoy) | 16.19% |
| Gross Profit (ttm) | 179.62M CNY |
| EBITDA | 86.79M CNY |
| Net Income Avi to Common (ttm) | 55.46M CNY |
| Diluted EPS (ttm) | 0.47 |
| Quarterly Earnings Growth (yoy) | -38.39% |
Balance Sheet
| Total Cash (mrq) | 440.1M CNY |
| Total Cash Per Share (mrq) | 3.67 CNY |
| Total Debt (mrq) | 37.54M CNY |
| Total Debt/Equity (mrq) | 2.6 CNY |
| Current Ratio (mrq) | 5.763 |
| Book Value Per Share (mrq) | 11.968 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 106.78M CNY |
| Levered Free Cash Flow (ttm) | -219573984 CNY |
Profile of Cabio Biotech (Wuhan) Co., Ltd.
| Country | China |
| State | N/A |
| City | Wuhan |
| Address | No. 999 high-tech Avenue |
| ZIP | 430073 |
| Phone | 86 27 6784 5351 |
| Website | https://www.cabio.cn |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 444 |
CABIO Biotech(Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human nutrition products, such as food products for special medical purpose, function food products, and dietary supplements; and animal nutrition and health products comprising fatty acid solutions. The company was founded in 1999 and is based in Wuhan, China.
Q&A For Cabio Biotech (Wuhan) Co., Ltd. Stock
What is a current 688089.SS stock price?
Cabio Biotech (Wuhan) Co., Ltd. 688089.SS stock price today per share is 13.36 CNY.
How to purchase Cabio Biotech (Wuhan) Co., Ltd. stock?
You can buy 688089.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cabio Biotech (Wuhan) Co., Ltd.?
The stock symbol or ticker of Cabio Biotech (Wuhan) Co., Ltd. is 688089.SS.
Which industry does the Cabio Biotech (Wuhan) Co., Ltd. company belong to?
The Cabio Biotech (Wuhan) Co., Ltd. industry is Biotechnology.
How many shares does Cabio Biotech (Wuhan) Co., Ltd. have in circulation?
The max supply of Cabio Biotech (Wuhan) Co., Ltd. shares is 168.31M.
What is Cabio Biotech (Wuhan) Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Cabio Biotech (Wuhan) Co., Ltd. PE Ratio is 133.59999000 now.
What was Cabio Biotech (Wuhan) Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Cabio Biotech (Wuhan) Co., Ltd. EPS is 0.1 CNY over the trailing 12 months.
Which sector does the Cabio Biotech (Wuhan) Co., Ltd. company belong to?
The Cabio Biotech (Wuhan) Co., Ltd. sector is Healthcare.